Abstract
The concept of encapsulated-cell therapy is very appealing, but in practice a great deal of technology and know-how is needed for the production of long-term functional transplants. Alginate is one of the most promising biomaterials for immunoisolation of allogeneic and xenogeneic cells and tissues (such as Langerhans islets). Although great advances in alginate-based cell encapsulation have been reported, several improvements need to be made before routine clinical applications can be considered. Among these is the production of purified alginates with consistently high transplantation-grade quality. This depends to a great extent on the purity of the input algal source as well as on the development of alginate extraction and purification processes that can be validated. A key engineering challenge in designing immunoisolating alginate-based microcapsules is that of maintaining unimpeded exchange of nutrients, oxygen and therapeutic factors (released by the encapsulated cells), while simultaneously avoiding swelling and subsequent rupture of the microcapsules. This requires the development of efficient, validated and well-documented technology for cross-linking alginates with divalent cations. Clinical applications also require validated technology for long-term cryopreservation of encapsulated cells to maintaining a product inventory in order to meet end-user demands. As shown here these demands could be met by the development of novel, validated technologies for production of transplantation-grade alginate and microcapsule engineering and storage. The advances in alginate-based therapy are demonstrated by transplantation of encapsulated rat and human islet grafts that functioned properly for about 1 year in diabetic mice.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
W. M. KÜHTREIBER, R. P. LANZA and W. L. CHICK, in “Cell Encapsulation Technology and Therapeutics” (BirkhÄuser, Boston, 1999).
R. P. LANZA, R. LANGER and J. VACANTI, in “Principles of Tissue Engineering” (Academic Press, San Diego, 2000).
U. ZIMMERMANN, S. MIMIETZ, H. ZIMMERMANN, M. HILLGÄRTNER, H. SCHNEIDER, J. LUDWIG, C. HASSE, A. HAASE, M. ROTHMUND and G. R. FUHR, BioTechniques 29(3) (2000) 564.
U. ZIMMERMANN, F. THÜRMER, A. JORK, M. WEBER, S. MIMIETZ, M. HILLGÄRTNER, F. BRUNNENMEIER, H. ZIMMERMANN, I. WESTPHAL, G. R. FUHR, U. NÖTH, A. HAASE, A. STEINERT and C. HENDRICH, Ann. N.Y. Acad. Sci. 944(1) (2001) 199.
C. HASSE, G. KLÖCK, A. SCHLOSSER, U. ZIMMERMANN and M. ROTHMUND, Lancet 350(9087) (1997) 1296.
T. G. WANG, in “Cell Encapsulation Technology and Therapeutics,” edited by W. M. KÜhtreiber, R. P. Lanza and W. L. Chick (BirkhÄuser, Boston, 1999) p. 29.
H. ZIMMERMANN, M. HILLGÄRTNER, B. MANZ, P. J. FEILEN, F. BRUNNENMEIER, U. LEINFELDER, M. WEBER, H. CRAMER, S. SCHNEIDER, C. HENDRICH, F. VOLKE and U. ZIMMERMANN, Biomaterials 24(12) (2003) 2083.
B. H. A. REHM, in “Biopolymers: Polysaccharides I: Polysaccharides from Prokaryotes,” edited by E. J. Vandamme, S. De Baets and A. SteinbÜchel (Wiley-VCH, Weinheim, 2002) Vol. 5, p. 179.
K. I. DRAGET, O. SMIDSRØD and G. SKJåK-BRÆK, in “Biopolymers: Polysaccharides II: Polysaccharides from Eukaryotes,” edited by S. De Baets, E. J. Vandamme and A. Steinbüchel (Wiley-VCH, Weinheim, 2002) Vol. 6, p. 215.
J. A. VÄSQUEZ, in “Coastal Plant Communities of Latin America,” edited by U. Seeliger (Academic Press, San Diego, 1992) p. 77.
M. VENEGAS, B. MATSUHIRO and M. E. EDDING, Botanica Marina 36 (1993) 47.
U. LEINFELDER, F. BRUNNENMEIER, H. CRAMER, J. SCHILLER, K. ARNOLD, J. A. VÄSQUEZ and U. ZIMMERMANN, Biomaterials 24(23) (2003) 4161.
B. MATTIASSON, in “Immobilized Cells and Organelles,” edited by B. Mattiasson (CRC Press, Boca Raton, 1983) Vol. I, p. 3.
M. DORNISH, D. KAPLAN and Ø.SKAUGRUD, Ann. N.Y. Acad. Sci. 944(1) (2001) 388.
M. A. ATKINSON and E. H. LEITER, Nat. Med. 5(6) (1999) 601.
J. WIJSMAN, P. ATKISON, R. MAZAHERI, B. GARCIA, T. PAUL, J. VOSE, G. O’SHEA and C. STILLER, Transplantation 54(4) (1992) 588.
U. ZIMMERMANN, C. HASSE, M. ROTHMUND and W. KÜHTREIBER, in “Cell Encapsulation Technology and Therapeutics,” edited by W. M. Kühtreiber, R. P. Lanza and W. L. Chick (BirkhÄuser, Boston, 1999) p. 40.
C. RYSER, J. WANG, S. MIMIETZ and U. ZIMMERMANN, J. Membr. Biol. 168(2) (1999) 183.
M. HEIDECKER, S. MIMIETZ, L. H. WEGNER and U. ZIMMERMANN, J. Membr. Biol. 192(2) (2003) 123.
M. HILLGÄRTNER, H. ZIMMERMANN, S. MIMIETZ, A. JORK, F. THÜRMER, H. SCHNEIDER, U. NÖTH, C. HASSE, A. HAASE, G. R. FUHR, M. ROTHMUND and U. ZIMMERMANN, Math.-Wiss. u. Werkstofftech. 30 (1999) 783.
S. SCHNEIDER, P. J. FEILEN, H. CRAMER, M. HILLGÄRTNER, F. BRUNNENMEIER, H. ZIMMERMANN, M. M. WEBER and U. ZIMMERMANN, J. Microencapsul. 20(5) (2003) 627.
U. ZIMMERMANN, H. CRAMER, A. JORK, F. THÜRMER, H. ZIMMERMANN, G. R. FUHR, C. HASSE and M. ROTHMUND, in “Biotechnology,” edited by H. J. Rehm and G. Reed (Wiley-VCH, Weinheim, 2001) Vol. 10, p. 547.
B. THU, O. GASEROD, D. PAUL, A. MIKKELSEN, G. SKJåK-BRÆK, R. TOFFANIN, F. VITTUR and R. RIZZO, Biopolymers 53(1) (2000) 60.
B. MANZ, M. HILLGÄRTNER, H. ZIMMERMANN, D. ZIMMERMANN, F. VOLKE and U. ZIMMERMANN, Eur. Biophys. J. 33(1) (2004) 50.
R. WOLF, J. Microsc. (London) 153 (1989) 181.
R. WOLF, in “Science, Technology and Education of Microscopy: an Overview,” edited by A. Mendez-Vilas (Formatex, Madrid, 2003) p. 720.
O. SMIDSRØD and G. SKJåK-BRÆK, Trends Biotechnol. 8(3) (1990) 71.
C. DULIEU, D. PONCELET and R. J. NEUFELD, in “Cell Encapsulation Technology and Therapeutics,” edited by W. M. KÜhtreiber, R. P. Lanza and W. L. Chick (BirkhÄuser, Boston, 1999) p. 3.
P. B. MESSERSMITH and S. STARKE, Chem. Mater. 10(1) (1998) 117.
M. E. WESTWOOD and P. J. THORNALLEY, in “The Glycation Hypothesis of Atherosclerosis,” edited by C. Colaco (Landes Bioscience, Georgetown, 1997) p. 57.
U. ZIMMERMANN and E. STEUDLE, Adv. Bot. Res. 6 (1978) 45.
J. DAINTY, Adv. Bot. Res. 1 (1963) 279.
E. O. STEJKAL and J. E. TANNER, J. Chem. Phys. 42 (1965) 288.
M. MAURO, Science 126 (1957) 252.
A. K. SOLOMON, J. Gen. Physiol. 51(5) (1968) 335.
E. ROBBINS and A. MAURO, ibid. 43(3) (1960) 523.
F. J. MARTIN and C. GROVE, Biomed. Microdiv. 3(2) (2001) 97.
S. SCHNEIDER, P. J. FEILEN, F. BRUNNENMEIER, U. ZIMMERMANN and M. M. WEBER, Diabetes 53(2) (2004) A 615.
J. H. CROWE and L. M. CROWE, Nat. Biotechnol. 18(2) (2000) 145.
A. EROGLU, M. J. RUSSO, R. BIEGANSKI, A. FOWLER, S. CHELEY, H. BAYLEY and M. TONER, Nat. Biotechnol. 18(2) (2000) 163.
H. ZIMMERMANN, A. D. KATSEN, F. R. IHMIG, CH. H. P. DURST, ST. G. SHIRLEY and G. R. FUHR, IEE Proc. Nanobiotechnol. 151(4) (2004) 134.
R. REUSS, J. LUDWIG, R. SHIRAKASHI, F. EHRHART, H. ZIMMERMANN, S. SCHNEIDER, M. M. WEBER, U. ZIMMERMANN, H. SCHNEIDER and V. L. SUKHORUKOV, J. Membr. Biol. 200(2) (2004) 67.
F. LANG, G. L. BUSCH and H. VÖLKL, Cell. Physiol. Biochem. 8(1/2) (1998) 1.
M. ESCH, V. L. SUKHORUKOV, M. KÜRSCHNER and U. ZIMMERMANN, Biopolymers 50(3) (1999) 227.
H. SCHNEIDER, N. WISTUBA, H. J. WAGNER, F. THÜRMER and U. ZIMMERMANN, New Phytol. 148(2) (2000) 221.
H. SCHNEIDER, B. MANZ, M. WESTHOFF, S. MIMIETZ, M. SZIMTENINGS, T. NEUBERGER, C. FABER, G. KROHNE, A. HAASE, F. VOLKE and U. ZIMMERMANN, New Phytol. 159(2) (2003) 487.
H. J. WAGNER, H. SCHNEIDER, S. MIMIETZ, N. WISTUBA, M. ROKITTA, G. KROHNE, A. HAASE and U. ZIMMERMANN, New Phytol. 148(2) (2000) 239.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zimmermann, H., Zimmermann, D., Reuss, R. et al. Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J Mater Sci: Mater Med 16, 491–501 (2005). https://doi.org/10.1007/s10856-005-0523-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10856-005-0523-2